RxDoctor Payments Data

Aarti Sarwal, MD

Neurocritical Care · Winston Salem, NCNPI 1043321011

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Biogen.

$74in general payments, 2019–2025

Across 1 payment — averaging $73.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$74
$133,395in research payments, 2019–2025

Across 11 payments — averaging $12,127 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biogen$48K
  • Butterfly Network, Inc.$48K
  • C. R. Bard, Inc. & Subsidiaries$27K
  • Novartis$10K

What the payments were for

  • Food & beverage$74100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen1$74

How this compares

Too few neurocritical care providers in North Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$8,611
Medicare patients
45
Services billed
90

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurocritical care in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →